Multi-colored header graphic

Strategies for effective collaboration between R&D and IP in pharma

Poor alignment between IP and R&D teams can be a massive risk to any drug development organization. The resulting lost data and reduced efficiency can hinder the process at every step.

Read this white paper to see seven strategies for fostering collaboration between these teams to ensure protection, minimize risk, and maximize potential for successful commercialization.

SIPPSPHMENGWHP101679 Synergizing Innovation Protection Whitepaper

Download the white paper

Your privacy is important to CAS. More detail about how we use your information is in our privacy policy.